Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small-cell Lung Cancer (NSCLC) Stage IIIb/IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01519804
What this trial is testing

Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Genentech, Inc. 108
Testing effectiveness (Phase 2)Study completedNCT00365547
What this trial is testing

Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy

Who this might be right for
Lung Cancer
Masonic Cancer Center, University of Minnesota 46
Testing effectiveness (Phase 2)Study completedNCT00087412
What this trial is testing

S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungLarge Cell Lung CancerRecurrent Non-small Cell Lung Cancer+3 more
National Cancer Institute (NCI) 65
Not applicableStudy completedNCT01999881
What this trial is testing

Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients

Who this might be right for
Extensive Stage Small Cell Lung CancerHealthy, no Evidence of DiseaseLimited Stage Small Cell Lung Cancer+9 more
University of Wisconsin, Madison 21
Large-scale testing (Phase 3)Ended earlyNCT01041781
What this trial is testing

Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 313
Large-scale testing (Phase 3)Ended earlyNCT00558636
What this trial is testing

A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bayer 91
Testing effectiveness (Phase 2)Ended earlyNCT01337154
What this trial is testing

First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Stage IIIB Non-small Cell Lung Cancer With Pleural EffusionStage IV Non-small Cell Lung Cancer
CytRx 140
Testing effectiveness (Phase 2)Study completedNCT00002656
What this trial is testing

Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00063895
What this trial is testing

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Non-small Cell Lung CancerRecurrent Ovarian Epithelial CancerRecurrent Squamous Cell Carcinoma of the Hypopharynx+27 more
National Cancer Institute (NCI) 80
Large-scale testing (Phase 3)UnknownNCT00004100
What this trial is testing

Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Istituto Nazionale per lo Studio e la Cura dei Tumori
Testing effectiveness (Phase 2)Study completedNCT00606502
What this trial is testing

Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment

Who this might be right for
Non-small Cell Lung Cancer
Spectrum Pharmaceuticals, Inc 201
Large-scale testing (Phase 3)UnknownNCT00004887
What this trial is testing

Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery

Who this might be right for
Lung Cancer
The Christie NHS Foundation Trust
Not applicableNot Yet RecruitingNCT06848426
What this trial is testing

Xingbai Ji Formula Combined with Chemotherapy and Sintilimab in Metastatic Multi-Target Mutation-Negative Non-Small Cell Lung Cancer: a Clinical Trial

Who this might be right for
Non-Small Cell Lung CancerNon-small Cell Lung Cancer RecurrentNon-small Cell Lung Cancer Stage IIIB+2 more
Jiangxi Provincial People's Hopital 100
Large-scale testing (Phase 3)Study completedNCT00883779
What this trial is testing

Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 451
Testing effectiveness (Phase 2)Study completedNCT00036920
What this trial is testing

TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT05132218
What this trial is testing

Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer

Who this might be right for
ALK PositiveNSCLC Stage IIIBNSCLC Stage IV
Peking University Cancer Hospital & Institute 180
Testing effectiveness (Phase 2)Study completedNCT02655913
What this trial is testing

Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+2 more
Clifford Hospital, Guangzhou, China 97
Testing effectiveness (Phase 2)WithdrawnNCT03370159
What this trial is testing

CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer

Who this might be right for
Stage IIIB Non-Small Cell Lung Cancer AJCC v7Stage IV Non-Small Cell Lung Cancer AJCC v7
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT00138203
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 16
Not applicableWithdrawnNCT02017925
What this trial is testing

Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation

Who this might be right for
CachexiaFatiguePulmonary Complications+5 more
Ohio State University Comprehensive Cancer Center
Next Page